A phase 1 trial of Elafin with subcutaneously administered in the US.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Tiprelestat (Primary)
- Indications Lung transplant rejection; Pulmonary arterial hypertension
- Focus Adverse reactions
- 23 Jan 2018 New trial record
- 18 Dec 2017 According to a Proteo Biotech media release, this NIH funded trial is expect to initiate the recruitment in 2018.